|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 3691 | Drugs / Medical | 09/21/2004
A class action has been filed against Yale New Haven Hospitals for failing to provide healthcare services to Connecticut residents regardless of their ability to pay. The lawsuit alleges that Yale has an obligation to provide free or low cost healthcare services because it operates as a non-profit organization and is exempt from federal, state and local taxes. According to the complaint, Yale’s website states that it will ‘provide sensitive, high quality, cost effective health care services to all patients, regardless of ability to pay’.
The lawsuit also alleges that Yale has charged substantially more to uninsured patients for medical services than they charged to insured patients for the same services. Yale has been accused of giving private insurance companies and governmental third party payers like Medicare and Medicaid large discounts, but has not offered the same rates to uninsured patients. In addition, the suit alleges that Yale has employed aggressive, abusive, and humiliating practices, including lawsuits, liens, and garnishments, to recover for medical debts. The suit points to several independent studies conducted over the past three years showing that Yale has received substantial revenues from their collection practices – much more than other non-profit organizations. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest Kahn Gauthier Swick is investigating cases in which persons have contracted Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis Syndrome (TENS), or Erythema multiforme (EM) after taking any of a number of drugs, including prescription nonsteroidal anti-inflammatory drugs Daypro (oxaprozin), and Bextra (valdecoxib), and the anti-rheumatoid drug Arava (leflunomide). The syndromes are potentially life-threatening inflammatory skin disorders that can also cause lesions on internal organs. If you or a loved one has suffered from any of these debilitating conditions, please contact Kahn Gauthier for more information. A class action lawsuit has been filed on behalf of uninsured patients who received and were billed for medical care by any hospital within the South Dakota based Avera Health network of hospitals. The suit contends that Avera billed its uninsured patients at rates far in excess of the rates employed for insured patients and that this practice was and is both discriminatory and illegal. A class action has been filed against drug manufacturer Impax Laboratories, Inc. (Nasdaq:IPXL) and certain of its officers and directors by stockholders who purchased the company’s common stock between May 5, 2004 and November 3, 2004. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company’s securities. The stockholders seek to recover compensatory damages for the loss of value of their stock. Several class actions have been filed against biopharmaceutical corporation Adolor Corporation (Nasdaq:ADLR) and certain of its officers and directors by stockholders who purchased the company's common stock between September 23, 2003, and January 14, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. A class action has been filed against Tripos, Inc. (Nasdaq: TRPS) and certain of its officers and directors by stockholders who purchased the company's common stock between January 9 and July 1, 2002. Reduction and even elimination of health care benefits is a growing source of controversy between U.S. corporations and their retirees. Two related class actions have been filed against Rexam, Inc.--the current owner of the American National Can Company--and the Rexam Retired Employees Group Insurance Plan on behalf of employees who retired from National Can and who now allege that Rexam has violated the federal Labor Management Relations Act and the Employee Retirement Income Security Act (ERISA) by unilaterally reducing retiree medical benefits. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
